Status:

COMPLETED

Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis

Lead Sponsor:

University of Arizona

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cystic Fibrosis

Healthy

Eligibility:

All Genders

15-55 years

Phase:

NA

Brief Summary

Our aims were to determine if exhaled breath condensate (EBC) could detect differences in ion regulation between cystic fibrosis (CF) and healthy and measure the effect of the albuterol on EBC ions in...

Eligibility Criteria

Inclusion

  • Healthy subjects:
  • no cardiovascular abnormalities
  • not overweight BMI\>25
  • 18-55 years of age
  • CF subjects:
  • mild to moderate CF (FEV1\>40% predicted)
  • clinically diagnosed with positive sweat test (sweat Cl-\>60mmol/L)
  • 10-55 years of age
  • clinically stable

Exclusion

  • Healthy subjects will be excluded if:
  • If unable to consent for him/herself (cognitive impairment)
  • Have a history or evidence of cardiovascular and/or pulmonary abnormalities.
  • Have an abnormal 12-lead EKG
  • Have an abnormal pulmonary function test
  • Have a history of asthma
  • Have a history of renal disease or estimated creatinine clearance \< 55ml/min
  • Women who are pregnant or planning to become pregnant during the study
  • CF subjects:
  • If unable to consent for him/herself (cognitive impairment)
  • Physically unable to perform exercise or breathing tests
  • Have a history of renal disease or estimated creatinine clearance \< 55ml/min
  • Women who are pregnant or planning to become pregnant during the study.
  • Have an abnormal 12-lead EKG
  • Cystic Fibrosis related diabetes is uncontrolled
  • Forced Expiratory Volume after 1 second (FEV1) is less than 40% predicted
  • Have a history of joint disease
  • Have history of pulmonary exacerbation within the last two weeks
  • Experienced pulmonary hemorrhage within 6 months resulting in greater than 50cc of blood in the sputum
  • not currently enrolled in any other research study

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT01880723

Start Date

May 1 2009

End Date

January 1 2013

Last Update

November 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona

Tucson, Arizona, United States, 85721